View by Specialty

Trending

PC0125Qi_Graphic_01_WEB
January 10, 2025
3 min read
Save

Drinking coffee in the morning reduces the risk for death

Women’s Health & OB/GYN News

SPONSORED CONTENT
January 17, 2025
2 min read
Save
Risks faced by some pregnant Medicaid enrollees highlight need for adequate postnatal care

Risks faced by some pregnant Medicaid enrollees highlight need for adequate postnatal care

The rates of opioid use disorder among pregnant people enrolled in Medicaid may be twice as high as prior estimates, according to a recent cross-sectional analysis published in JAMA Network Open.

SPONSORED CONTENT
January 17, 2025
4 min read
Save

Q&A: How women with PCOS can boost fertility

Q&A: How women with PCOS can boost fertility

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Judy Simon, MS, RDN, CD, CHES, FAND, about nutrition and other lifestyle considerations for women with polycystic ovary syndrome seeking to conceive.

SPONSORED CONTENT
January 17, 2025
2 min read
Save

Zoledronate infusions every 5 years may lower fracture risk for early postmenopausal women

Zoledronate infusions every 5 years may lower fracture risk for early postmenopausal women

Early postmenopausal women who receive zoledronate every 5 years have a lower risk for morphometric vertebral fractures than those receiving placebo, according to trial findings published in The New England Journal of Medicine.

Trending

PC0125Qi_Graphic_01_WEB
January 10, 2025
3 min read
Save

Drinking coffee in the morning reduces the risk for death

SPONSORED CONTENT
January 17, 2025
3 min read
Save

Breast cancer survivors with BRCA mutations at greater risk for second primary malignancies

Breast cancer survivors with <i>BRCA</i> mutations at greater risk for second primary malignancies

Breast cancer survivors who harbor BRCA gene mutation are at elevated risk for second primary cancers, according to study results.

SPONSORED CONTENT
January 16, 2025
2 min read
Save

Study: Three-quarters of infants protected against RSV last season

Study: Three-quarters of infants protected against RSV last season

Nearly 80% of infants born in a California health system were exposed to nirsevimab or the maternal respiratory syncytial virus vaccine in 2023-2024, the first season in which they were available, according to study findings.

SPONSORED CONTENT
January 16, 2025
2 min read
Save

Gestational diabetes, asthma link highlights need for early screening in pregnant women

Gestational diabetes, asthma link highlights need for early screening in pregnant women

Gestational diabetes led to an increased risk for asthma exacerbations during pregnancy among a cohort of women with pre-existing asthma, according to results of a retrospective cohort study.

SPONSORED CONTENT
January 16, 2025
2 min read
Save

National support for expanded access to medication abortion rose since Dobbs

National support for expanded access to medication abortion rose since <i>Dobbs</i>

National support for expanded medication abortion access, including advance provision and over-the-counter availability, rose since the Dobbs decision, particularly among women residing in abortion-restrictive states, survey data show.

SPONSORED CONTENT
January 16, 2025
5 min read
Save

Cancer burden increasing among younger women, report shows

Cancer burden increasing among younger women, report shows

Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according to an American Cancer Society report.

SPONSORED CONTENT
January 16, 2025
3 min read
Save

Race, sex disparities persist in weight-loss surgery

Race, sex disparities persist in weight-loss surgery

Men were less likely than women to have weight-loss surgery, and that gap has widened over time, while Black patients were less likely than those of other races to have a procedure, and that gap has narrowed slightly, new data show.

SPONSORED CONTENT
January 16, 2025
3 min read
Save

Adjuvant regimen extends survival in early HER2-positive breast cancer

Adjuvant regimen extends survival in early HER2-positive breast cancer

Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with HER2-positive breast cancer, according to long-term results of a randomized phase 3 trial.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails